Skip to main content
. 2019 Dec 31;11:10929–10937. doi: 10.2147/CMAR.S231901

Figure 1.

Figure 1

(AD) Kaplan-Meier survival curves for prognosis according to different levels of post-treatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR): (A, B) post-PLR <263.0 and post-NLR <6.5 predicted better progression-free survival with log rank test p-value of p=0.02 and p=0.01, respectively; (C, D): post-PLR <263.0 and post-NLR<6.5 predicted better overall survival with log rank test p-value of p=0.009 and p=0.002, respectively.